Intelligence · Clinical Development
Pipeline search results
Programs matching “qing” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 138 pipeline programs matching "qing" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
1.0mg/kg/day PRAX-562
Chongqing Precision Biotech Co., Ltd
Developmental and Epileptic Encephalopathy 1
1 trial -
18F fluciclovine
Chongqing Precision Biotech Co., Ltd
Brain Metastases
2 trials -
1mg elsunersen
Chongqing Precision Biotech Co., Ltd
Epileptic Encephalopathy
1 trial -
20mg/day PRAX-628 for 6 weeks then 30mg/day PRAX-628 for remaining 6 weeks
Chongqing Precision Biotech Co., Ltd
Focal Seizure
1 trial -
40 mg/day vormatrogine for 12 weeks
Chongqing Precision Biotech Co., Ltd
Focal Epilepsy
1 trial -
60 mg ulixacaltamide
Chongqing Precision Biotech Co., Ltd
Essential Tremor
1 trial -
Early Vasopressin
Chongqing Precision Biotech Co., Ltd
Septic Shock
1 trial -
Gum chewing
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Recovery of Bowel Function, Due to Gum Chewing
1 trial -
Houyanqing Oral Liquid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Cancinoma (NPC)
1 trial -
ICT-107
Chongqing Precision Biotech Co., Ltd
Glioblastoma Multiforme
2 trials -
Lidocaine spray
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Uterine Cervical Dysplasia
1 trial -
Lidocaine spray
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Uterine Bleeding
1 trial -
Mevac-A vaccine
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
HAV
1 trial -
PRAX-114
Chongqing Precision Biotech Co., Ltd
Major Depressive Disorder
1 trial -
PRAX-222
Chongqing Precision Biotech Co., Ltd
Voltage-gated sodium channel type II alpha subunit (SCN2A) developmental and epileptic encephalopathy (DEE)
1 trial -
PRAX-562
Chongqing Precision Biotech Co., Ltd
SCN2A Encephalopathy
1 trial -
PRAX-628-322
Chongqing Precision Biotech Co., Ltd
Focal Epilepsy
1 trial -
PRAX-628-323
Chongqing Precision Biotech Co., Ltd
Focal onset seizures or primary generalized tonic-clonic seizures.
1 trial -
Placebo for PRAX-628, PRAX-628
Chongqing Precision Biotech Co., Ltd
Focal Epilepsy
1 trial -
Qing'E pills
Universal Integrated
Menopause
1 trial -
Yinhu Qingwen Granula
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
metronomic adjuvant chemotherapy with capecitabine
Chongqing Claruvis Pharmaceutical Co.,
Nasopharyngeal Cancinoma (NPC)
1 trial -
vormatrogine
Chongqing Precision Biotech Co., Ltd
Epilepsy, Tonic-Clonic
1 trial -
10 mg PRAX-114
Chongqing Precision Biotech Co., Ltd
Major Depressive Disorder
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.